[1] |
王卫平, 孙锟, 常立文. 儿科学[M]. 9版. 北京: 人民卫生出版社, 2018.
|
[2] |
Olusanya B O, Michael K, Hansen T. Neonatal hyperbilirubinaemia:a global perspective[J]. Lancet Child & Adolescent Health, 2018, 2(8):610-620.
|
[3] |
韦当, 王聪尧, 肖晓娟, 等. 指南研究与评价(AGREEⅡ)工具实例解读[J]. 中国循证儿科杂志, 2013, 8(4):316-319.
|
[4] |
张方圆, 沈傲梅, 曾宪涛, 等. 系统评价方法学质量评价工具AMSTAR 2解读[J]. 中国循证心血管医学杂志, 2018, 10(1):14-18.
|
[5] |
胡雁, 郝玉芳. 循证护理学[M]. 2版. 北京: 人民卫生出版社, 2018.
|
[6] |
林楠, 诸纪华, 徐红贞, 等. 早产儿体位管理的最佳证据总结[J]. 中华护理杂志, 2022, 57(4):486-492.
doi: 10.3761/j.issn.0254-1769.2022.04.016
|
[7] |
王春青, 胡雁. JBI证据预分级及证据推荐级别系统(2014版)[J]. 护士进修杂志, 2015, 30(11):964-967.
|
[8] |
Anand P, Chairperson M S, Gopalakrishnan S, et al. Screening,prevention,and management of neonatal hyperbilirubinemia guideline development group(Alphabetical)[J]. Journal of Neonatology, 2020, 34(3):153-169.
doi: 10.1177/0973217920974163
|
[9] |
National Institute for Health and Care Excellence. Jaundice in newborn babies under 28 days[EB/OL]. (2016-10-26)[2022-04-02]. https://www.nice.org.uk/guidance/cg98.
|
[10] |
Queensland Clinical Guidelines:Neonatal jaundice[EB/OL]. (2019-06-10)[2022-03-26]. https://guide.medlive.cn/guideline/18351.
|
[11] |
Çoban A, Türkmen MK, Gürsoy T. Turkish Neonatal Society guideline to the approach,follow-up,and treatment of neonatal jaundice[J]. Turk Pediatri Ars, 2018, 53(Suppl 1):S172-S179.
|
[12] |
Feng Q, Huang ZY, Su LJ, et al. Therapeutic efficacy and safety of Yinzhihuang granules with phototherapy in neonatal pathologic jaundice:an updated systematic review and meta-analysis[J]. Phytomedicine, 2022, 100:154051.
doi: 10.1016/j.phymed.2022.154051
|
[13] |
van Rostenberghe H, Ho JJ, Lim CH, et al. Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia[J]. Cochrane Database Syst Rev, 2020, 7:CD012011.
|
[14] |
杨爱玲, 冯雅敏, 张有成. 抚触和穴位按摩配合蓝光照射治疗新生儿黄疸效果的Meta分析[J]. 西部中医药, 2021, 34(6):67-74.
|
[15] |
张霞, 韩姗姗, 丁樱, 等. 清肝利胆口服液治疗新生儿黄疸的有效性和安全性评价[J]. 河南中医, 2019, 39(6):871-877.
|
[16] |
Wong RJ, Bhutani VK. Unconjugated hyperbilirubinemia in term and late preterm infants:management[EB/OL]. (2021-12-02)[2022-03-26]. http://www-uptodate-com-443.bjmu.ilibs.cn/contents/unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants-management.
|
[17] |
Wong RJ, Bhutani VK. Unconjugated hyperbilirubinemia in term and late preterm infants:screening[EB/OL]. (2021-10-22)[2022-03-26]. http://www-uptodate-com-443.bjmu.ilibs.cn/contents/unconjugated-hyperbilirubinemia-in-term-and-late-preterm-infants-screening.
|
[18] |
Wong RJ, Bhutani VK. Unconjugated hyperbilirubinemia in the newborn:interventions[EB/OL].(2021-11-10)[2022-03-26]. http://www-uptodate-com-443.bjmu.ilibs.cn/contents/unconjugated-hyperbilirubinemia-in-the-newborn-interventions.
|
[19] |
MSpPath GK. Neonatal jaundice:phototherapy[EB/OL]. (2021-04-07)[2022-03-24]. https://ovidsp.dc1.ovid.com/ovid-a/ovidweb.cgi?&S=AIPGFPMIPIACPGIBKPNJAGPMAOMKAA00&Link+Set=S.sh.21%7c1%7csl_190.
|
[20] |
中华医学会儿科学分会新生儿学组,《中华儿科杂志》编辑委员会. 新生儿高胆红素血症诊断和治疗专家共识[J]. 中华儿科杂志, 2014, 52(10):745-748.
|
[21] |
张巍, 侯新琳. 新生儿黄疸管理流程共识[J]. 中国优生与遗传杂志, 2021, 29(3):297-299.
|
[22] |
Wickremasinghe AC, Kuzniewicz MW, McCulloch CE, et al. Efficacy of subthreshold newborn phototherapy during the birth hospitalization in preventing readmission for phototherapy[J]. JAMA Pediatr, 2018, 172(4):378-385.
doi: 10.1001/jamapediatrics.2017.5630
pmid: 29482208
|
[23] |
Chang PW, Kuzniewicz MW, McCulloch CE, et al. A clinical prediction rule for rebound hyperbilirubinemia following inpatient phototherapy[J]. Pediatrics, 2017, 139(3):e20162896.
doi: 10.1542/peds.2016-2896
|
[24] |
Grosse SD, Prosser LA, Botkin JR. Screening for neonatal hyperbilirubinemia-first do no harm?[J]. JAMA Pediatr, 2019, 173(7):617-618.
doi: 10.1001/jamapediatrics.2019.1194
pmid: 31107538
|
[25] |
Ogunlesi TA, Lesi FE, Oduwole O. Prophylactic intravenous calcium therapy for exchange blood transfusion in the newborn[J]. Cochrane Database Syst Rev, 2017, 10(10):CD011048.
|